1 XMR = $311.96
Buy
Retatrutide: Next-Gen Peptide not ozempic
0.75 XMR
(≈ $233.97)
(1)
(1)
Rating N/A (0 reviews)
Stock
Unlimited stock
Location
United States
Delivery
  • Domestic shipping - 0.05 XMR
Payment
  • Direct payment (XMR)
  • Multisig escrow (beta) (XMR)


Rating N/A (0 reviews)
Member since Oct 2025

Retatrutide: Next-Gen Peptide not ozempic

Description

Unlock the potential of advanced metabolic research with **Retatrutide**, a powerful 100mg research peptide designed exclusively for in vitro testing and laboratory experimentation. This innovative compound offers unparalleled insights into metabolic pathways, surpassing traditional options like Ozempic with its unique triple-receptor activation. Dive into the future of scientific discovery with a product crafted for precision and efficacy.

**What’s Included:**
- 100mg high-purity Retatrutide powder
- 30ml bacteriostatic reconstitution solution
- 10-pack of 1ml sterile syringes for accurate dosing

**Why Choose Retatrutide?**
Imagine a research tool that redefines the boundaries of metabolic studies. Retatrutide’s triple-agonist mechanism targets **GLP-1**, **GIP**, and **Glucagon receptors**, driving groundbreaking results in energy metabolism, lipid oxidation, and insulin sensitivity. Clinical studies have shown up to **24.2% body weight reduction** in just 48 weeks and **86% liver fat reduction** in MASLD research, setting a new standard for efficacy. Its ability to enhance fat oxidation and reduce hepatic steatosis makes it a game-changer for researchers exploring obesity and metabolic disorders.

**Product Details:**
- **For Research Use Only**: Strictly for laboratory and in vitro experimentation, not for human or animal use.
- **Prohibited Misuse**: Not a drug, food, or cosmetic—must be handled by licensed professionals.
- **Stock**: Unlimited availability
- **Location**: United States
- **Delivery**: Domestic shipping for only 0.05 XMR
- **Payment Options**: Direct payment (XMR) or Multisig escrow (beta) (XMR)
- **Price**: 0.75 XMR (≈ $225.44)

**Research Highlights:**
- **Triple Receptor Agonism**: Simultaneously activates GLP-1, GIP, and Glucagon receptors for comprehensive metabolic impact.
- **Proven Results**: Phase 2 trials show dose-dependent weight loss (up to 24.2% at 12mg) and significant liver fat reduction (up to 86% at 48 weeks).
- **Metabolic Benefits**: Increases energy expenditure, enhances lipid metabolism, and reduces dihydroceramides by 20.1%.

**Ready to Elevate Your Research?**
Step into the forefront of metabolic science with Retatrutide. Perfect for researchers seeking precise, reliable, and transformative results. Order now and experience the future of laboratory innovation!

**Category**: Health
**Tags**: Retatrutide, GLP-1, GIP, Glucagon, Obesity Research, Metabolic Disorders, Weight Management, Liver Health, Peptide Research, Triple Agonist, MASLD, Fat Oxidation, Insulin Sensitivity
**Published**: October 1, 2025
**Views**: 5

**Legal Notice**: This product is for research purposes only and not intended for diagnostic, therapeutic, or human/animal use. Buyers and sellers must comply with all applicable laws. XmrBazaar does not verify legality and assumes no liability. Listings involving fraud, violence, or illegal goods are prohibited and will be removed. Report unlawful listings promptly.

Category: Other

Tags: Retatrutide, GLP-1, GIP, Glucagon, Obesity Research, Metabolic Disorders, Weight Management, Liver Health, Peptide Research, Triple Agonist, MASLD, Fat Oxidation, Insulin Sensitivity

Published on: October 1, 2025

Views: 4

Legal Notice: Buyers and sellers are responsible for complying with all applicable laws in their jurisdictions. XmrBazaar does not verify legality and assumes no liability. Peer-to-peer cash-for-crypto trades are permitted if not conducted as a business and are compliant with local laws; otherwise, sellers must hold any required licenses or registrations. Listings involving fraud, violence, child exploitation, or other clearly illegal goods or services are strictly prohibited and will be removed once identified. Users are encouraged to report unlawful listings.

N/A stars overall - 0 reviews for this listing
No reviews yet
0 comments for this listing
No comments yet

About the trader

N/A (0 reviews)
Member since October 2025
About me

N/A

Links

N/A

PGP key
-----BEGIN PGP PUBLIC KEY BLOCK-----
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=jy3s
-----END PGP PUBLIC KEY BLOCK-----